249 related articles for article (PubMed ID: 29631156)
1. Tuberous sclerosis complex: Concerns and needs of patients and parents from the transitional period to adulthood.
Both P; Ten Holt L; Mous S; Patist J; Rietman A; Dieleman G; Ten Hoopen L; Vergeer M; de Wit MC; Bindels-de Heus K; Moll H; van Eeghen A
Epilepsy Behav; 2018 Jun; 83():13-21. PubMed ID: 29631156
[TBL] [Abstract][Full Text] [Related]
2. Experience of follow-up, quality of life, and transition from pediatric to adult healthcare of patients with tuberous sclerosis complex.
Bar C; Ghobeira R; Azzi R; Ville D; Riquet A; Touraine R; Chemaly N; Nabbout R
Epilepsy Behav; 2019 Jul; 96():23-27. PubMed ID: 31077938
[TBL] [Abstract][Full Text] [Related]
3. Healthcare transition from childhood to adulthood in Tuberous Sclerosis Complex.
Peron A; Canevini MP; Ghelma F; Di Marco F; Vignoli A
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):355-364. PubMed ID: 30253036
[TBL] [Abstract][Full Text] [Related]
4. Growing up with Fragile X Syndrome: Concerns and Care Needs of Young Adult Patients and Their Parents.
Van Remmerden MC; Hoogland L; Mous SE; Dierckx B; Coesmans M; Moll HA; Lubbers K; Lincken CR; Van Eeghen AM
J Autism Dev Disord; 2020 Jun; 50(6):2174-2187. PubMed ID: 30879259
[TBL] [Abstract][Full Text] [Related]
5. Worries and needs of adults and parents of adults with neurofibromatosis type 1.
Rietman AB; van Helden H; Both PH; Taal W; Legerstee JS; van Staa A; Moll HA; Oostenbrink R; van Eeghen AM
Am J Med Genet A; 2018 May; 176(5):1150-1160. PubMed ID: 29681082
[TBL] [Abstract][Full Text] [Related]
6. Renal manifestations of tuberous sclerosis complex: patients' and parents' knowledge and routines for renal follow-up - a questionnaire study.
Cockerell I; Guenin M; Heimdal K; Bjørnvold M; Selmer KK; Rouvière O
BMC Nephrol; 2018 Feb; 19(1):39. PubMed ID: 29439672
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers.
Hamer HM; Pfäfflin M; Baier H; Bösebeck F; Franz M; Holtkamp M; Kurlemann G; May TW; Mayer T; Metzner M; Steinhoff BJ; Stodieck S; Straub HB; Weber YG; Brandt C
Epilepsy Behav; 2018 May; 82():64-67. PubMed ID: 29587187
[TBL] [Abstract][Full Text] [Related]
8. Involvement of mental health professionals in the treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey.
Waltereit R; Beaure d'Augères G; Jancic J; Kingswood JC; Koleva M; Marques R; Villanueva V; Auvin S
Orphanet J Rare Dis; 2021 May; 16(1):216. PubMed ID: 33980296
[TBL] [Abstract][Full Text] [Related]
9. 'We've made the best of it. But we do not have a normal life': families' experiences of tuberous sclerosis complex and seizure management.
McDonald A; Goodwin J; Roberts S; Fish L; Vaughan B; Cooper A; Cadwgan J
J Intellect Disabil Res; 2019 Aug; 63(8):947-956. PubMed ID: 30775832
[TBL] [Abstract][Full Text] [Related]
10. Self-injury and aggression in adults with tuberous sclerosis complex: Frequency, associated person characteristics, and implications for assessment.
Wilde L; Eden K; de Vries P; Moss J; Welham A; Oliver C
Res Dev Disabil; 2017 May; 64():119-130. PubMed ID: 28411579
[TBL] [Abstract][Full Text] [Related]
11. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist.
Leclezio L; Jansen A; Whittemore VH; de Vries PJ
Pediatr Neurol; 2015 Jan; 52(1):16-24. PubMed ID: 25499093
[TBL] [Abstract][Full Text] [Related]
12. International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ; Heunis TM; Vanclooster S; Chambers N; Bissell S; Byars AW; Flinn J; Gipson TT; van Eeghen AM; Waltereit R; Capal JK; Cukier S; Davis PE; Smith C; Kingswood JC; Schoeters E; Srivastava S; Takei M; Gardner-Lubbe S; Kumm AJ; Krueger DA; Sahin M; De Waele L; Jansen AC
J Neurodev Disord; 2023 Sep; 15(1):32. PubMed ID: 37710171
[TBL] [Abstract][Full Text] [Related]
13. Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study.
Ebrahimi-Fakhari D; Hussong J; Flotats-Bastardas M; Ebrahimi-Fakhari D; Zemlin M; von Gontard A; Meyer S
Neuropediatrics; 2019 Oct; 50(5):294-299. PubMed ID: 31266065
[TBL] [Abstract][Full Text] [Related]
14. Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM.
Müller AR; Luijten MAJ; Haverman L; de Ranitz-Greven WL; Janssens P; Rietman AB; Ten Hoopen LW; de Graaff LCG; de Wit MC; Jansen AC; Gipson T; Capal JK; de Vries PJ; van Eeghen AM
BMC Med; 2023 Aug; 21(1):298. PubMed ID: 37553648
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric comorbidities in tuberous sclerosis complex patients with epilepsy: results of the TAND checklist survey.
Lee HY; Lin CH; Wang XA; Tsai JD
Acta Neurol Belg; 2024 Jun; 124(3):973-979. PubMed ID: 38523222
[TBL] [Abstract][Full Text] [Related]
16. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
[TBL] [Abstract][Full Text] [Related]
17. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
[TBL] [Abstract][Full Text] [Related]
18. The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial.
Randell E; McNamara R; Davies DM; Owen-Jones E; Kirby N; Angel L; Drew C; Cannings-John R; Smalley M; Saxena A; McDermott E; Stockwell L; de Vries PJ; Hood K; Sampson JR
Trials; 2016 Aug; 17():398. PubMed ID: 27515417
[TBL] [Abstract][Full Text] [Related]
19. Neurological and neuropsychiatric aspects of tuberous sclerosis complex.
Curatolo P; Moavero R; de Vries PJ
Lancet Neurol; 2015 Jul; 14(7):733-45. PubMed ID: 26067126
[TBL] [Abstract][Full Text] [Related]
20. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Kingswood JC; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2018 Sep; 13(1):157. PubMed ID: 30201051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
